Naloxegol

Pharm Company: * MSN LABS PVT LTD
Category: Opioid Dependence

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Naloxegol Overview

Naloxegol (INN; PEGylated naloxol;[1] trade names Movantik and Moventig) is a peripherally acting μ-opioid receptor antagonist developed by AstraZeneca, licensed from Nektar Therapeutics, for the treatment of opioid-induced constipation.[2] It was approved in 2014 in adult patients with chronic, non-cancer pain.[3] Doses of 25mg were found safe and well tolerated for 52 weeks.[4] When given concomitantly with opioid analgesi...

Read more Naloxegol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Naloxegol

Recent Naloxegol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Naloxegol
  • Tablet: 12 Mg. + 25 Mg., 12.5mg, 25mg
  • Unknown: Unknown
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Naloxegol or a similar ingredient: (1 result)